Vistin Pharma ASA (OSL:VISTN)

Market Cap	1.06B
Revenue (ttm)	429.50M
Net Income (ttm)	62.75M
Shares Out	44.34M
EPS (ttm)	1.42
PE Ratio	16.96
Forward PE	n/a
Dividend	1.25 (5.21%)
Ex-Dividend Date	Jun 4, 2025

Volume	4,162
Average Volume	19,164
Open	23.40
Previous Close	23.40
Day's Range	23.00 - 23.40
52-Week Range	20.70 - 28.80
Beta	0.93
RSI	51.82
Earnings Date	Apr 25, 2025

About Vistin Pharma ASA

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. Vistin Pharma ASA was founded in 1969 and is headquartered in Oslo, Norway.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1969
• Employees: 77
• Stock Exchange: Oslo Børs
• Ticker Symbol: VISTN

Financial Performance

In 2024, Vistin Pharma ASA's revenue was 429.50 million, a decrease of -2.01% compared to the previous year's 438.33 million. Earnings were 62.75 million, an increase of 37.63%.